After successfully completing initial safety and feasibility trials, Quietmind Foundation, in cooperation with Texas A&M and Baylor Research Institute, are enrolling adults (50-85) with memory loss for a new innovative clinical study.
About The Clinical Trial
In cooperation with Texas A&M University's Dept. of Neurosurgery, Quietmind Foundation is enrolling individuals age 50-85 years experiencing memory problems and who have been independently diagnosed with early to mid-stage dementia to participate in this trial. The study uses low-level light stimulation directed to the head. The stimulation sessions are conducted at home, twice daily, for 5 minutes over 60 consecutive days. The trial is randomized, placebo controlled and double blind.
All study-related services are provided at no cost and local travel costs are covered.
After completing three, two-hour assessments all subjects are paid a total of $225.
What's involved in this trial?
Individuals that match the clinical trial eligibility criteria will go through two unique assessments at the start, mid-point, and ending of the trial period.
Participants re-do the EEG and cognitive assessments twice more during the two month trial.